NVO 주가 차트
NVO 주가 예측
Novo Nordisk A/S
$48.02
0.8%
$0.38
오늘 기준:Jun 26, 12:08:51 GMT-4
뒤로
Novo Nordisk A/S (NVO) 주가 예측
주요 통계
이전 종가
$47.64
시가
$47.12
일일 범위
$46.99 - $48.5
52주 범위
$35.12 - $71.8
거래량
8.1M
평균 거래량
15.3M
배당수익률
--
EPS(TTM)
4.26
시가총액
$161.0B
Novo Nordisk A/S란 무엇인가요?
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
